Skip to main content
Equibles

MML INVESTORS SERVICES, LLC

Position in GMAB — Genmab A/S

CIK 701059 SPRINGFIELD, MA
Back to GMAB Full portfolio

Position in GMAB

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$1,536,891
+$511,181 QoQ
Shares Held
55,948
+46.3% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#75
of 292 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in GMAB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MML INVESTORS SERVICES, LLC holds $86,570,832 across 61 Biotechnology names. GMAB ranks #13 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 38,907 $19,326,274
2 REGN
Regeneron Pharmaceuticals, Inc.
 18,117 $11,296,674
3 ARGX
Argenx SE
 6,825 $6,332,030
4 EXEL
Exelixis, Inc.
 73,531 $4,000,821
5 INSM
INSMED Inc
 32,823 $3,499,588
6 ALNY
Alnylam Pharmaceuticals, Inc.
 9,949 $2,994,947
7 JAZZ
Jazz Pharmaceuticals plc
 11,712 $2,822,240
8 RPRX
Royalty Pharma plc
 49,942 $2,800,247

All Filings in GMAB

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,536,891 55,948
2026-03-31 $1,025,710 38,230
2025-12-31 $1,208,869 39,249
2025-09-30 $1,165,091 37,988
2025-06-30 $796,980 38,576
2025-03-31 $914,895 46,726
2024-12-31 $920,596 44,111
2024-09-30 $1,786,103 73,261
2024-06-30 $1,745,931 69,476
2024-03-31 $2,430,037 81,245
2023-12-31 $2,390,865 75,090
2023-09-30 $1,776,973 50,382
2023-06-30 $1,552,784 40,852
2023-03-31 $1,316,540 34,866
2022-12-31 $1,548,649 36,542
2022-09-30 $1,077,093 33,523
2022-06-30 $828,170 25,490
2022-03-31 $920,563 25,444
2021-12-31 $1,049,922 26,540
2021-09-30 $1,073,577 24,567
2021-06-30 $905,568 22,179
2021-03-31 $651,051 19,831
2020-12-31 $641,940 15,788
2020-09-30 $468,864 12,807
2020-06-30 $408,442 12,052